CN112315860A - Chinese herbal medicine system infant hip-protecting cream and preparation method thereof - Google Patents
Chinese herbal medicine system infant hip-protecting cream and preparation method thereof Download PDFInfo
- Publication number
- CN112315860A CN112315860A CN202011127148.3A CN202011127148A CN112315860A CN 112315860 A CN112315860 A CN 112315860A CN 202011127148 A CN202011127148 A CN 202011127148A CN 112315860 A CN112315860 A CN 112315860A
- Authority
- CN
- China
- Prior art keywords
- extract
- parts
- herbal medicine
- chinese herbal
- infant hip
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000006071 cream Substances 0.000 title claims abstract description 75
- 241000411851 herbal medicine Species 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title description 6
- 239000000284 extract Substances 0.000 claims abstract description 57
- 239000003755 preservative agent Substances 0.000 claims abstract description 22
- 230000002335 preservative effect Effects 0.000 claims abstract description 18
- 230000000844 anti-bacterial effect Effects 0.000 claims abstract description 14
- 241000736199 Paeonia Species 0.000 claims abstract description 13
- 235000006484 Paeonia officinalis Nutrition 0.000 claims abstract description 13
- 241000207929 Scutellaria Species 0.000 claims abstract description 10
- 239000003921 oil Substances 0.000 claims description 29
- 235000019198 oils Nutrition 0.000 claims description 29
- 235000013399 edible fruits Nutrition 0.000 claims description 20
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 15
- 240000001548 Camellia japonica Species 0.000 claims description 14
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims description 12
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 claims description 10
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 240000002024 Gossypium herbaceum Species 0.000 claims description 7
- 235000004341 Gossypium herbaceum Nutrition 0.000 claims description 7
- 235000018597 common camellia Nutrition 0.000 claims description 7
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 claims description 6
- 240000007817 Olea europaea Species 0.000 claims description 6
- 238000000034 method Methods 0.000 claims description 6
- 229940101267 panthenol Drugs 0.000 claims description 6
- 235000020957 pantothenol Nutrition 0.000 claims description 6
- 239000011619 pantothenol Substances 0.000 claims description 6
- 239000011787 zinc oxide Substances 0.000 claims description 6
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 claims description 5
- PHOQVHQSTUBQQK-SQOUGZDYSA-N D-glucono-1,5-lactone Chemical compound OC[C@H]1OC(=O)[C@H](O)[C@@H](O)[C@@H]1O PHOQVHQSTUBQQK-SQOUGZDYSA-N 0.000 claims description 5
- 239000004264 Petrolatum Substances 0.000 claims description 5
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 claims description 5
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 claims description 5
- 235000012209 glucono delta-lactone Nutrition 0.000 claims description 5
- 229960003681 gluconolactone Drugs 0.000 claims description 5
- 229940051250 hexylene glycol Drugs 0.000 claims description 5
- -1 liquid paraffin Substances 0.000 claims description 5
- 229940057995 liquid paraffin Drugs 0.000 claims description 5
- 239000004200 microcrystalline wax Substances 0.000 claims description 5
- 235000019808 microcrystalline wax Nutrition 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- 235000019271 petrolatum Nutrition 0.000 claims description 5
- 229940066842 petrolatum Drugs 0.000 claims description 5
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 claims description 4
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 claims description 4
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 claims description 4
- 229940036350 bisabolol Drugs 0.000 claims description 4
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 235000011187 glycerol Nutrition 0.000 claims description 4
- 229940114937 microcrystalline wax Drugs 0.000 claims description 4
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 claims description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 4
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 3
- 229940043375 1,5-pentanediol Drugs 0.000 claims description 3
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 3
- 235000005979 Citrus limon Nutrition 0.000 claims description 3
- 244000131522 Citrus pyriformis Species 0.000 claims description 3
- 241000208473 Macadamia ternifolia Species 0.000 claims description 3
- BVTHRGZMQHOCOL-UHFFFAOYSA-N OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO Chemical compound OCC(O)(C1(NC(=O)NCNC(=O)NC2(CO)NC(=O)NC2=O)NC(=O)NC1=O)CO BVTHRGZMQHOCOL-UHFFFAOYSA-N 0.000 claims description 3
- 229960000686 benzalkonium chloride Drugs 0.000 claims description 3
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 claims description 3
- 230000003750 conditioning effect Effects 0.000 claims description 3
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 claims description 3
- 239000003205 fragrance Substances 0.000 claims description 3
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 claims description 3
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 claims description 3
- 229960005323 phenoxyethanol Drugs 0.000 claims description 3
- MXOAEAUPQDYUQM-QMMMGPOBSA-N (S)-chlorphenesin Chemical compound OC[C@H](O)COC1=CC=C(Cl)C=C1 MXOAEAUPQDYUQM-QMMMGPOBSA-N 0.000 claims description 2
- IBLKWZIFZMJLFL-UHFFFAOYSA-N 1-phenoxypropan-2-ol Chemical compound CC(O)COC1=CC=CC=C1 IBLKWZIFZMJLFL-UHFFFAOYSA-N 0.000 claims description 2
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 2
- RWLALWYNXFYRGW-UHFFFAOYSA-N 2-Ethyl-1,3-hexanediol Chemical compound CCCC(O)C(CC)CO RWLALWYNXFYRGW-UHFFFAOYSA-N 0.000 claims description 2
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- 229940100484 5-chloro-2-methyl-4-isothiazolin-3-one Drugs 0.000 claims description 2
- 239000005711 Benzoic acid Substances 0.000 claims description 2
- 235000004936 Bromus mango Nutrition 0.000 claims description 2
- 235000005976 Citrus sinensis Nutrition 0.000 claims description 2
- 240000002319 Citrus sinensis Species 0.000 claims description 2
- 241000675108 Citrus tangerina Species 0.000 claims description 2
- 240000000560 Citrus x paradisi Species 0.000 claims description 2
- 239000004166 Lanolin Substances 0.000 claims description 2
- 240000007228 Mangifera indica Species 0.000 claims description 2
- 235000014826 Mangifera indica Nutrition 0.000 claims description 2
- 240000001659 Oldenlandia diffusa Species 0.000 claims description 2
- 235000002725 Olea europaea Nutrition 0.000 claims description 2
- 235000019482 Palm oil Nutrition 0.000 claims description 2
- 240000001341 Reynoutria japonica Species 0.000 claims description 2
- 235000018167 Reynoutria japonica Nutrition 0.000 claims description 2
- 240000004980 Rheum officinale Species 0.000 claims description 2
- 235000008081 Rheum officinale Nutrition 0.000 claims description 2
- 235000009184 Spondias indica Nutrition 0.000 claims description 2
- 244000299461 Theobroma cacao Species 0.000 claims description 2
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 235000010233 benzoic acid Nutrition 0.000 claims description 2
- 229960004365 benzoic acid Drugs 0.000 claims description 2
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 claims description 2
- 239000004327 boric acid Substances 0.000 claims description 2
- 229960002645 boric acid Drugs 0.000 claims description 2
- 235000010338 boric acid Nutrition 0.000 claims description 2
- DHNRXBZYEKSXIM-UHFFFAOYSA-N chloromethylisothiazolinone Chemical compound CN1SC(Cl)=CC1=O DHNRXBZYEKSXIM-UHFFFAOYSA-N 0.000 claims description 2
- 229960003993 chlorphenesin Drugs 0.000 claims description 2
- 239000001260 citrus sinensis l. osbeck fruit oil Substances 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 229960004698 dichlorobenzyl alcohol Drugs 0.000 claims description 2
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 claims description 2
- 229960005082 etohexadiol Drugs 0.000 claims description 2
- SXCBDZAEHILGLM-UHFFFAOYSA-N heptane-1,7-diol Chemical compound OCCCCCCCO SXCBDZAEHILGLM-UHFFFAOYSA-N 0.000 claims description 2
- 235000019388 lanolin Nutrition 0.000 claims description 2
- 229940039717 lanolin Drugs 0.000 claims description 2
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 claims description 2
- 239000002540 palm oil Substances 0.000 claims description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 2
- 229940106026 phenoxyisopropanol Drugs 0.000 claims description 2
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 claims description 2
- 239000004302 potassium sorbate Substances 0.000 claims description 2
- 235000010241 potassium sorbate Nutrition 0.000 claims description 2
- 229940069338 potassium sorbate Drugs 0.000 claims description 2
- 229960004889 salicylic acid Drugs 0.000 claims description 2
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 claims description 2
- 239000004299 sodium benzoate Substances 0.000 claims description 2
- 235000010234 sodium benzoate Nutrition 0.000 claims description 2
- 229960003885 sodium benzoate Drugs 0.000 claims description 2
- 239000004334 sorbic acid Substances 0.000 claims description 2
- 235000010199 sorbic acid Nutrition 0.000 claims description 2
- 229940075582 sorbic acid Drugs 0.000 claims description 2
- 235000014121 butter Nutrition 0.000 claims 2
- DBHODFSFBXJZNY-UHFFFAOYSA-N 2,4-dichlorobenzyl alcohol Chemical compound OCC1=CC=C(Cl)C=C1Cl DBHODFSFBXJZNY-UHFFFAOYSA-N 0.000 claims 1
- 240000000031 Achyranthes bidentata Species 0.000 claims 1
- 244000245214 Mentha canadensis Species 0.000 claims 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 claims 1
- 244000236658 Paeonia lactiflora Species 0.000 claims 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 claims 1
- 241000972673 Phellodendron amurense Species 0.000 claims 1
- 235000009470 Theobroma cacao Nutrition 0.000 claims 1
- 229940002386 calendula officinalis extract Drugs 0.000 claims 1
- 229960005150 glycerol Drugs 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 10
- 239000004519 grease Substances 0.000 abstract description 8
- 230000002421 anti-septic effect Effects 0.000 abstract description 6
- 125000003118 aryl group Chemical group 0.000 abstract description 5
- 230000000638 stimulation Effects 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 3
- 230000002588 toxic effect Effects 0.000 abstract description 3
- 239000002537 cosmetic Substances 0.000 description 12
- 230000000670 limiting effect Effects 0.000 description 11
- 238000012360 testing method Methods 0.000 description 10
- 238000000227 grinding Methods 0.000 description 9
- 239000002994 raw material Substances 0.000 description 9
- 235000006467 Camellia japonica Nutrition 0.000 description 7
- 201000004624 Dermatitis Diseases 0.000 description 7
- 230000000052 comparative effect Effects 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 5
- 244000003027 Bergamotto Species 0.000 description 5
- 210000001217 buttock Anatomy 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 230000007794 irritation Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000014692 zinc oxide Nutrition 0.000 description 5
- 240000001432 Calendula officinalis Species 0.000 description 4
- 244000025254 Cannabis sativa Species 0.000 description 4
- 206010015150 Erythema Diseases 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 244000179970 Monarda didyma Species 0.000 description 4
- 235000010672 Monarda didyma Nutrition 0.000 description 4
- IPQKDIRUZHOIOM-UHFFFAOYSA-N Oroxin A Natural products OC1C(O)C(O)C(CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IPQKDIRUZHOIOM-UHFFFAOYSA-N 0.000 description 4
- UILPJVPSNHJFIK-UHFFFAOYSA-N Paeonol Chemical compound COC1=CC=C(C(C)=O)C(O)=C1 UILPJVPSNHJFIK-UHFFFAOYSA-N 0.000 description 4
- 239000010404 Scutellaria baicalensis extract Substances 0.000 description 4
- IKIIZLYTISPENI-ZFORQUDYSA-N baicalin Chemical compound O1[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 IKIIZLYTISPENI-ZFORQUDYSA-N 0.000 description 4
- 229960003321 baicalin Drugs 0.000 description 4
- AQHDANHUMGXSJZ-UHFFFAOYSA-N baicalin Natural products OC1C(O)C(C(O)CO)OC1OC(C(=C1O)O)=CC2=C1C(=O)C=C(C=1C=CC=CC=1)O2 AQHDANHUMGXSJZ-UHFFFAOYSA-N 0.000 description 4
- LRFDUPNLCDXZOE-UHFFFAOYSA-N camellianin b Chemical compound OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(OC=2C=3C(=O)C=C(OC=3C=C(O)C=2)C=2C=CC(O)=CC=2)OC1CO LRFDUPNLCDXZOE-UHFFFAOYSA-N 0.000 description 4
- 229960004551 cotton seed extract Drugs 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- 238000010298 pulverizing process Methods 0.000 description 4
- 238000013112 stability test Methods 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 230000000153 supplemental effect Effects 0.000 description 4
- 206010012444 Dermatitis diaper Diseases 0.000 description 3
- 208000003105 Diaper Rash Diseases 0.000 description 3
- 241000208467 Macadamia Species 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010040880 Skin irritation Diseases 0.000 description 3
- 241001122767 Theaceae Species 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 231100000475 skin irritation Toxicity 0.000 description 3
- 230000036556 skin irritation Effects 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 2
- 239000004475 Arginine Substances 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 235000003880 Calendula Nutrition 0.000 description 2
- 235000005881 Calendula officinalis Nutrition 0.000 description 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 description 2
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 2
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 2
- 240000004534 Scutellaria baicalensis Species 0.000 description 2
- 235000017089 Scutellaria baicalensis Nutrition 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 2
- 239000004473 Threonine Substances 0.000 description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 235000004279 alanine Nutrition 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000003704 aspartic acid Nutrition 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 235000012343 cottonseed oil Nutrition 0.000 description 2
- 239000002385 cottonseed oil Substances 0.000 description 2
- 229960003067 cystine Drugs 0.000 description 2
- 235000014113 dietary fatty acids Nutrition 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 229930195729 fatty acid Natural products 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 239000003862 glucocorticoid Substances 0.000 description 2
- 235000013922 glutamic acid Nutrition 0.000 description 2
- 239000004220 glutamic acid Substances 0.000 description 2
- ACCCMOQWYVYDOT-UHFFFAOYSA-N hexane-1,1-diol Chemical compound CCCCCC(O)O ACCCMOQWYVYDOT-UHFFFAOYSA-N 0.000 description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- YLTGFGDODHXMFB-UHFFFAOYSA-N isoacetovanillon Natural products COC1=CC=C(C(C)=O)C=C1O YLTGFGDODHXMFB-UHFFFAOYSA-N 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- MLIBGOFSXXWRIY-UHFFFAOYSA-N paeonol Natural products COC1=CC=C(O)C(C(C)=O)=C1 MLIBGOFSXXWRIY-UHFFFAOYSA-N 0.000 description 2
- 210000002640 perineum Anatomy 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229940051841 polyoxyethylene ether Drugs 0.000 description 2
- 229920000056 polyoxyethylene ether Polymers 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 210000000689 upper leg Anatomy 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- DNIAPMSPPWPWGF-VKHMYHEASA-N (+)-propylene glycol Chemical compound C[C@H](O)CO DNIAPMSPPWPWGF-VKHMYHEASA-N 0.000 description 1
- 239000001500 (2R)-6-methyl-2-[(1R)-4-methyl-1-cyclohex-3-enyl]hept-5-en-2-ol Substances 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- 229940031723 1,2-octanediol Drugs 0.000 description 1
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 1
- 229940035437 1,3-propanediol Drugs 0.000 description 1
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- TZZGHGKTHXIOMN-UHFFFAOYSA-N 3-trimethoxysilyl-n-(3-trimethoxysilylpropyl)propan-1-amine Chemical compound CO[Si](OC)(OC)CCCNCCC[Si](OC)(OC)OC TZZGHGKTHXIOMN-UHFFFAOYSA-N 0.000 description 1
- RFWGABANNQMHMZ-UHFFFAOYSA-N 8-acetoxy-7-acetyl-6,7,7a,8-tetrahydro-5H-benzo[g][1,3]dioxolo[4',5':4,5]benzo[1,2,3-de]quinoline Natural products CC=C1C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(C(=O)OC)=COC1OC1OC(CO)C(O)C(O)C1O RFWGABANNQMHMZ-UHFFFAOYSA-N 0.000 description 1
- 241000427159 Achyranthes Species 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 229920000742 Cotton Polymers 0.000 description 1
- HKVGJQVJNQRJPO-UHFFFAOYSA-N Demethyloleuropein Natural products O1C=C(C(O)=O)C(CC(=O)OCCC=2C=C(O)C(O)=CC=2)C(=CC)C1OC1OC(CO)C(O)C(O)C1O HKVGJQVJNQRJPO-UHFFFAOYSA-N 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000219146 Gossypium Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 description 1
- 206010022562 Intermittent claudication Diseases 0.000 description 1
- 238000008214 LDL Cholesterol Methods 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 240000007575 Macadamia integrifolia Species 0.000 description 1
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- RFWGABANNQMHMZ-HYYSZPHDSA-N Oleuropein Chemical group O([C@@H]1OC=C([C@H](C1=CC)CC(=O)OCCC=1C=C(O)C(O)=CC=1)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RFWGABANNQMHMZ-HYYSZPHDSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 241000972672 Phellodendron Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 241000304195 Salvia miltiorrhiza Species 0.000 description 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229920006322 acrylamide copolymer Polymers 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 206010003119 arrhythmia Diseases 0.000 description 1
- 230000006793 arrhythmia Effects 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007797 corrosion Effects 0.000 description 1
- 238000005260 corrosion Methods 0.000 description 1
- 230000001186 cumulative effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 230000001877 deodorizing effect Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000008157 edible vegetable oil Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- MHIBEGOZTWERHF-UHFFFAOYSA-N heptane-1,1-diol Chemical compound CCCCCCC(O)O MHIBEGOZTWERHF-UHFFFAOYSA-N 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000021156 intermittent vascular claudication Diseases 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 229940105902 mint extract Drugs 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000008820 moutan cortex Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000344 non-irritating Toxicity 0.000 description 1
- 230000000474 nursing effect Effects 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- OEIJHBUUFURJLI-UHFFFAOYSA-N octane-1,8-diol Chemical compound OCCCCCCCCO OEIJHBUUFURJLI-UHFFFAOYSA-N 0.000 description 1
- RFWGABANNQMHMZ-CARRXEGNSA-N oleuropein Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)C(=CC)[C@H]1CC(=O)OCCc3ccc(O)c(O)c3 RFWGABANNQMHMZ-CARRXEGNSA-N 0.000 description 1
- 235000011576 oleuropein Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 1
- KMNONFBDPKFXOA-UHFFFAOYSA-N prop-2-enamide;styrene Chemical compound NC(=O)C=C.C=CC1=CC=CC=C1 KMNONFBDPKFXOA-UHFFFAOYSA-N 0.000 description 1
- 239000011241 protective layer Substances 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 231100000022 skin irritation / corrosion Toxicity 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229940102541 sodium trideceth sulfate Drugs 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000018553 tannin Nutrition 0.000 description 1
- 239000001648 tannin Substances 0.000 description 1
- 229920001864 tannin Polymers 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/005—Preparations for sensitive skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/524—Preservatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
- A61K2800/592—Mixtures of compounds complementing their respective functions
- A61K2800/5922—At least two compounds being classified in the same subclass of A61K8/18
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a Chinese herbal medicine system infant hip-protecting cream which comprises the following components in parts by weight: 10-50 parts of a skin conditioner, 0.1-10 parts of a Chinese herbal medicine antibacterial preservative, 5-30 parts of grease, 5-30 parts of a supplementary aid, 0-5 parts of an aromatic and 10-80 parts of water; the Chinese herbal medicine antibacterial preservative comprises a peony extract and a scutellaria extract. The Chinese herbal medicine system infant hip-protecting cream product disclosed by the invention is warm, moist, nourishing, strong in antibacterial action, unchanged in effect stability, free of stimulation to human skin and free of toxic and side effects; by using the Chinese herbal medicine antiseptic system, the Chinese herbal medicine components in the hip-protecting cream serve as the antiseptic system, and the hip-protecting cream is moist, non-greasy, good in texture, easy to smear and absorb, mild, fresh and cool, moistens and cares delicate skin of infants, and avoids red hips.
Description
Technical Field
The invention relates to the field of skin care, in particular to a Chinese herbal medicine system infant hip-protecting cream and a preparation method thereof.
Background
Diaper rash, also known as diaper rash, refers to redness of the skin at the diaper site of a newborn, such as around the anus, buttocks, thighs, perineum, etc., with scattered maculopapules or herpes. The main inducement is that the baby diaper is not changed frequently or washed cleanly, and the skin of the baby is contacted and irritated for a long time; or the diaper is hard and is caused by local friction; and exacerbation following a secondary bacterial or candida infection.
However, the protective layer of the infant's skin has not yet developed completely and thus the external stimuli are more easily penetrated. In particular, the infant skin has not developed a defense against certain bacteria, is more susceptible to infection, and has not developed an immune system that is sufficiently effective against infection. Infants also have a weaker ability to sweat, which reduces their ability to regulate body temperature through sweating, which may lead to diaper rash. The fat content of the skin of infants is higher, which makes fat-soluble substances (which may be irritants) more likely to penetrate the skin. Therefore, the autoimmune function of the newborn is not perfect, the skin is easy to be stimulated by the outside to generate a series of skin inflammatory reactions, and diaper dermatitis eczema belongs to common skin inflammatory pathological changes of the infants. Causes of occurrence generally include: when wet diapers are used, diapers which are not cleaned by washing products such as soap and the like are not replaced timely, and the like, the skin of the baby is very delicate and is easy to be stimulated by external stimulation to generate irritation reaction, and symptoms such as pruritus, redness and the like appear.
Most of the products on the market today use cosmetic preservative systems, which achieve preservative function by using quasi-industrial preservatives, such as imidazolidinyl urea, bis (hydroxymethyl) imidazolidinyl urea, benzalkonium chloride, phenoxyethanol, etc. Although the skin-care preservative belongs to the approved preservatives in the technical Specification for cosmetic safety, the skin-care preservative still has harm to the skin, and particularly the skin of infants is more fragile and seriously even aggravates the symptoms of skin inflammation, red rash, pruritus and the like.
The Chinese herbal medicine generally has the characteristics of mild effect, small irritation and high safety, is ideal when being used as a preservative, and has the advantages of lasting and stable effect, mild effect, wide application range, no side effect or small side effect, so the research and development of the Chinese herbal medicine become the latest trend of complying with the concept of returning to nature, scientific cosmetology and scientific nursing. In the application practice of external application and oral administration for thousands of years, a lot of drug effect records and experiences are accumulated in the traditional Chinese herbal medicine in China, and the dosage, safety and side effects of the traditional Chinese herbal medicine are verified. In particular, when these cosmetics are used for infants, various problems occur, such as high irritation, unsatisfactory use effect, and the like.
Besides the need of avoiding some adverse effects, the actual using effect of the infant hip-care cream needs to be further improved, for example, the infant hip-care cream has strong antibacterial effect, stable effect, no stimulation to the skin of infants, no toxic or side effect and radically avoids the problem of skin inflammation.
Disclosure of Invention
In view of the problems in the prior art, one of the objectives of the present invention is to provide a herbal ointment for protecting the buttocks of infants.
The invention also aims to provide a preparation method of the Chinese herbal medicine system infant hip-protecting cream.
Further, the invention also aims to provide a using method of the Chinese herbal medicine system infant hip-protecting cream.
The invention adopts the following technical scheme:
as a specific embodiment, the Chinese herbal medicine system infant hip-care cream comprises the following components in parts by weight:
the Chinese herbal medicine antibacterial preservative comprises a peony extract and a scutellaria extract.
Further, as a preferred embodiment, the Chinese herbal medicine system infant hip-care cream comprises the following components:
the term "Chinese herbal medicine" as used herein has the meaning conventionally understood in the field of traditional Chinese medicine, and Chinese herbal medicine is mainly composed of botanical herbs (roots, stems, leaves, fruits) and the like. And the preparation process also has the method or means which is conventionally used in the field of traditional Chinese medicine, such as cutting, air drying, sun drying, baking, grinding, extracting and the like.
Further, the Chinese herbal medicine antibacterial preservative accounts for 0.1-10 parts (based on the weight of the Chinese herbal medicine system infant hip care cream), such as 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1,2, 3, 4, 5, 6, 7, 8, 9 or 10 parts.
As a preferred exemplary embodiment, the Chinese herbal medicine antibacterial preservative comprises the following components in a weight ratio of 0.5-2: 1 peony extract and scutellaria extract. For example, the Chinese herbal medicine antibacterial preservative is prepared from the following components in parts by weight: 3 peony extract and scutellaria extract. Optionally, the Chinese herbal medicine antibacterial preservative is prepared from the following raw materials in a weight ratio of 1: 1 peony extract and scutellaria extract. Optionally, the Chinese herbal medicine antibacterial preservative is prepared from the following raw materials in a weight ratio of 1.5: 1 peony extract and scutellaria extract.
Specifically, the peony extract is prepared by washing moutan cortex radicis and/or moutan radicis, grinding and pulverizing (for example, grinding and pulverizing to 800-1200 mesh, preferably 1000 mesh), extracting by steaming, filtering at 1000-1500 mesh, preferably 1200 mesh, purifying, and drying.
The term "peony extract" as used herein is also known as root bark of peony, root bark of moutan, root bark of Salvia miltiorrhiza. The peony (bark) extract is also called paeonol. In the application, paeonol is used for treating symptoms such as acute skin eczema, pruritus and the like, and has obvious curative effect.
Specifically, the scutellaria baicalensis extract is prepared by washing scutellaria baicalensis, grinding and pulverizing (for example, grinding and pulverizing to 800-1200 mesh, preferably 1000 mesh), extracting by boiling, then filtering at 1000-1500 mesh, preferably 1200 mesh, purifying, and drying.
The term "scutellaria" as used herein, also known as camellia root or camellia japonica root, is a perennial herb of the genus scutellaria of the family labiatae.
Baicalin (Baicalin) is a flavonoid compound extracted and separated from scutellaria baicalensis (root), has obvious biological activity, has the effects of bacteriostasis, diuresis, anti-inflammation, allergy resistance and spasmolysis, has strong physiological effects of anticancer reaction and the like, and plays an important role in clinical medicine. Baicalin can absorb ultraviolet rays, remove oxygen free radicals and inhibit the generation of melanin, so that the baicalin can be used for medicines and cosmetics and is a good raw material for functional cosmetic.
Further, the skin conditioning agent comprises 10-50 parts (based on the weight of the herbal system infant hip care cream), such as 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49 or 50 parts.
Further, the skin conditioner comprises at least one of camellia seed oil, gossypium herbaceum seed extract, tocopheryl acetate, bisabolol (or alpha-bisabolol), macadamia ternifolia seed oil, olive fruit extract, calendula extract, panthenol, and glycerin.
The INCI (i.e., the International Chinese name catalog for cosmetic raw materials standards) of the term "Camellia JAPONICA (Camellia JAPONICA SEED OIL" as used herein is named "Camellia JAPONICA SEED OIL". The source may be commercially available, for example from the company Leternal Nature Shanghai Boshu industries, ITEM CODE: HT 1128. Camellia JAPONICA (Camellia JAPONICA) seed oil is obtained from Camellia JAPONICA seed, contains fatty acid, camellin, tea polyphenols, saponin, tannin, and is rich in antioxidant, squalene and flavonoid with antiinflammatory effect. The camellia seed oil is also rich in vitamin E and trace elements such as calcium, iron, zinc and the like, wherein the types of amino acids contained in the camellia seed oil are the most abundant in all edible oils, and the camellia seed oil also contains tea polyphenol and camellin (namely tea saponin) which are specific physiological active substances not contained in olive oil. Optionally, the camellia oil comprises 5-10 parts (based on the weight of the skin conditioner or the weight of the herbal system infant hip care cream), such as 5, 6, 7, 8, 9 or 10 parts.
As used herein, the INCI (catalog of International cosmetic raw materials for Chinese nomenclature) for "Gossypium HERBACEUM SEED extract" is called "Gossypium HERBACEUM SEED OIL", which is called "natural hydrogenated OIL", which is rich in high quality vitamins, fatty acids and sterols, which are combined in perfect proportions and complement each other to achieve unique skin care properties of COTTON OIL. The molecules of the fermented cottonseed oil are smaller and are easier to be absorbed by skin; after fermentation, the absorption rate of the cottonseed oil by a human body is higher. The source may be commercially available, for example from the company Literna Nature Shanghai Boshu industries, ITEM CODE: S10090. Optionally, the gossypium herbaceum seed extract is present in an amount of 8-14 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 8, 9, 10, 11, 12, 13, or 14 parts.
Further, the grass cotton seed extract comprises 1-3 wt% of alanine, 3-6 wt% of arginine, 1.5-5.5 wt% of aspartic acid, 0.1-1.5 wt% of cystine, 7-10 wt% of glutamic acid, 1-3.5 wt% of glycine, 0.5-3 wt% of histidine, 0.5-3 wt% of isoleucine, 1.5-4 wt% of leucine, 0.5-3 wt% of lysine, 0.1-3 wt% of methionine, 1-4 wt% of phenylalanine, 1-3 wt% of proline, 1-3 wt% of serine, 0.5-3 wt% of threonine, 0.1-2 wt% of tryptophan, 0.1-3 wt% of tyrosine, and 0.5-3 wt% of valine based on the weight of the grass cotton seed extract.
As an exemplary embodiment, the grass cotton seed extract comprises 1.81 wt% alanine, 4.4 wt% arginine, 4.02 wt% aspartic acid, 0.64 wt% cystine, 8.47 wt% glutamic acid, 1.83 wt% glycine, 1.45 wt% histidine, 1.27 wt% isoleucine, 2.55 wt% leucine, 1.57 wt% lysine, 0.70 wt% methionine, 2.23 wt% phenylalanine, 1.62 wt% proline, 2.04 wt% serine, 1.52 wt% threonine, 0.51 wt% tryptophan, 0.98 wt% tyrosine, 1.80 wt% valine, based on the weight of the grass cotton seed extract.
Optionally, the tocopheryl acetate is present in an amount of 0.5-2 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system baby hip care cream), such as 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9 or 2 parts.
Optionally, the bisabolol comprises 0.5-1.5 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, or 1.5 parts.
The INCI (i.e., International catalog of Chinese names for Standard cosmetic raw materials) name for the term "macadamia Persica (MACADAMIA INTEGRIFOLIA) seed oil" as used herein is "MACADAMIA INTEGRIFOLIASEED OIL". The source may be commercially available, for example from the company Leternal Nature Shanghai Boshu industries, Inc. Optionally, the macadamia whole-edge nut seed oil comprises 4-10 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 4, 5, 6, 7, 8, 9, or 10 parts.
The term "olive fruit extract" as used herein is mainly derived from the leaves of olive trees, the main component of the extract is oleuropein, the source of which may be commercially available. The olive fruit extract can relieve discomfort caused by insufficient arterial vascular flow, including angina pectoris and vascular intermittent claudication. It helps to eliminate atrial fibrillation (arrhythmia), lower hypertension and inhibit oxidation to produce LDL cholesterol. Optionally, the olive fruit extract comprises 5-10 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 5, 6, 7, 8, 9, or 10 parts.
As used herein, the INCI (i.e., the International Chinese nomenclature catalogue for cosmetic raw materials standards) name of the term "marigold (Calendilla OFFICINALIS) flower extract" is "Calendilla OFFICINALIS flower extract". The source may be purchased commercially. Optionally, the calendula (calendula officinalis) flower extract is present in an amount of 0.1-1 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9 or 1 part.
The term "panthenol" as used herein, also known as panthenol, is a vitamin B5 derivative, commonly referred to as "previtamin B5". Optionally, the panthenol is present in 0.1-1 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, or 1 part.
Optionally, the glycerin comprises 8-14 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), such as 8, 9, 10, 11, 12, 13, or 14 parts.
Further, the herbal antiseptic further comprises at least one of phellodendron extract, achyranthes extract, polygonum cuspidatum extract, rheum officinale extract, radix paeoniae alba extract, mint extract and oldenlandia diffusa extract, and the amount of the herbal antiseptic can be 10-30 parts, or 10-20 parts, or 20-30 parts (based on the weight of the skin conditioner, or based on the weight of the herbal system infant hip care cream), as a non-limiting example.
Further, the oil and fat accounts for 5-30 parts (based on the weight of the Chinese herbal medicine system infant hip care cream), such as 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30 parts.
Further, the grease (or a substance having grease properties) includes at least one of petrolatum, liquid paraffin, microcrystalline wax, gluconolactone, dioctyl carbonate, coconut oil, palm oil, mango seed fat, cacao seed fat, beeswax, and lanolin. Optionally, the grease (or substance having grease properties) comprises petrolatum, liquid paraffin, microcrystalline wax, gluconolactone, and dioctyl carbonate.
By way of non-limiting example, petrolatum may be used in amounts of 3-8 parts (based on the weight of the oil, or based on the weight of the herbal system infant hip care cream), such as 3, 4, 5, 6, 7 or 8 parts.
As a non-limiting example, the liquid paraffin may be used in an amount of 1 to 5 parts (based on the weight of the grease, or based on the weight of the herbal system infant hip care cream), for example, 1,2, 3, 4, or 5 parts.
By way of non-limiting example, the liquid microcrystalline wax may be used in an amount of 1-5 parts (based on the weight of the oil or fat, or based on the weight of the herbal system infant hip care cream), such as 1,2, 3, 4, or 5 parts.
By way of non-limiting example, the amount of liquid gluconolactone may be 1-2 parts (based on the weight of the oil or fat, or based on the weight of the herbal system infant hip care cream), such as 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2.
As a non-limiting example, the amount of liquid dioctyl carbonate may be 1-2 parts (based on the weight of the grease, or based on the weight of the herbal system infant hip care cream), such as 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, or 2.
Further, the supplementary aid includes at least one of zinc oxide, propylene glycol (e.g., 1, 3-propanediol), butylene glycol, pentylene glycol (e.g., 1, 2-pentanediol), hexylene glycol (e.g., 1, 2-hexanediol), heptanediol, octanediol (e.g., 1, 2-octanediol). Optionally, the supplemental aid comprises zinc oxide and hexylene glycol.
By way of non-limiting example, zinc oxide may be used in an amount of 7 to 15 parts (based on the weight of the supplemental aid, or based on the weight of the herbal system infant hip care cream), such as 7, 8, 9, 10, 11, 12, 13, 14, or 15 parts. The zinc oxide has the effects of deodorizing, resisting bacteria, astringing, protecting and improving the health condition of skin after being used together with other components.
By way of non-limiting example, hexylene glycol may be used in an amount of 3 to 8 parts (based on the weight of the supplemental aid, or based on the weight of the herbal system infant hip care cream), such as 3, 4, 5, 6, 7, or 8 parts. The hexanediol in the application has the effects of dissolving and preserving after being used together with other components, can ensure that the texture of the skin care product is lighter and thinner, is easier to smear and push away when in use, and can preserve corrosion to avoid the components from going bad or rotten. Propylene glycol, butylene glycol, pentylene glycol, heptylene glycol, octylene glycol may be interchanged with and/or used with hexylene glycol.
Further, the aromatic agent is 0-5 parts (based on the weight of the Chinese herbal medicine system infant hip care cream), such as 0, 0.01, 0.02, 0.03, 0.04, 0.05, 0.06, 0.07, 0.08, 0.09, 0.1, 0.2, 0.3, 0.4, 0.5, 0.6, 0.7, 0.8, 0.9, 1, 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2, 3, 4 or 5 parts.
Further, the aromatic comprises at least one of lemon fruit oil, sweet orange fruit oil, tangerine fruit oil and grapefruit fruit oil. Optionally, the aromatic is lemon fruit oil or bergamot (Citrus aurantium bergamia) fruit oil. In particular, the fragrance is not a perfume commonly understood in the art, such as a chemical perfume, an artificial perfume. As an example, the fragrance is a natural fruit oil and/or a natural essential oil.
As used herein, the INCI (i.e., International catalog of names in Standard for cosmetic raw materials, Chinese) name of "Citrus AURANTIUM Bergamia (BERGAMOT) FRUIT OIL" of the term "Citrus AURANTIUM Bergamia (Citrus AURANTIUM BERGAMIA) FRUIT OIL" is "Citrus AURANTIUM Bergamia (Citrus BERGAMOT) FRUIT OIL".
Further, the water accounts for 10-80 parts (based on the weight of the Chinese herbal medicine system infant hip care cream), such as 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 70 or 80 parts.
As a preferred exemplary embodiment, the herbal system infant hip care cream is free of non-herbal preservatives including phenoxyethanol, dichlorobenzyl alcohol, phenoxyisopropanol, benzalkonium chloride, imidazolidinyl urea, bis (hydroxymethyl) imidazolidinyl urea, benzyl alcohol, benzoic acid, salicylic acid, boric acid, sorbic acid, potassium sorbate, sodium benzoate, chlorphenesin, methylchloroisothiazolinone, methylisothiazolinone.
Furthermore, the Chinese herbal medicine system infant hip-protecting cream does not contain or contain dioxane, sodium dodecyl sulfate, sodium dodecyl polyoxyethylene ether sulfate, sodium trideceth sulfate, ammonium dodecyl polyoxyethylene ether sulfate, styrene-acrylamide copolymer and the like.
Further, the preparation method of the Chinese herbal medicine system infant hip-protecting cream comprises the following steps: mixing the components according to the proportion.
Specifically, as a non-limiting embodiment, a portion of the fat and a portion of the supplemental aid are mixed and heated to 70 ℃ to 90 ℃, preferably 80 ℃ to 85 ℃, to be completely melted;
adding part of skin conditioner and the rest oil into the melted mixed oil, stirring and mixing, and keeping the temperature to obtain an oil phase;
dissolving the remaining skin conditioning agent, the herbal antimicrobial preservative, and the remaining supplementary adjuvant in water, placing in another container, and heating to 75-85 deg.C (such as 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, or 85 deg.C) to obtain water phase;
adding the oil phase into the water phase under stirring, and grinding to emulsify;
optionally, adding aromatic (fruit oil) when the temperature is reduced to 40-60 deg.C (such as 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60 deg.C, preferably 50 deg.C), grinding thoroughly until emulsification is complete, and cooling to room temperature to obtain the hip-protecting cream.
The raw materials used in the present invention may be generally commercially available or may be prepared according to the operating specifications in the industry unless otherwise specified.
As an example, the use method of the Chinese herbal medicine system infant hip-protecting cream comprises the following steps: the infant hip-protecting cream is applied to the external body parts of an infant, such as the buttocks and the legs, or other parts (such as the face, the chest, the back, the arms and the like), and is lightly applied and massaged, so that the infant hip-protecting cream in a Chinese herbal medicine system is absorbed by the skin of the infant.
As used herein, "and/or" includes any and all combinations of one or more of the associated listed items. The terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. As used herein, the singular forms "a", "an" and "the" are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms "comprises" and/or "comprising," when used in this specification, specify the presence of stated features, integers, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, integers, steps, operations, elements, components, and/or groups thereof.
Unless defined otherwise, all terms (including technical and scientific terms) used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. It will be further understood that terms, such as those defined in commonly used dictionaries, should be interpreted as having a meaning that is consistent with their meaning in the context of the relevant art and will not be interpreted in an idealized or overly formal sense unless expressly so defined herein.
The exemplary invention described herein may suitably lack any one or more of the element limitations, which are not specifically disclosed herein. Thus, the terms "comprising," "including," "containing," and the like are to be construed broadly and in a non-limiting sense. Furthermore, the terms used herein are used as terms of description and not of limitation, and there is no intention in the use of such terms to describe only some of their characteristics but, in the light of the claims, various modifications are possible within the scope of the invention. Thus, while the present invention has been particularly disclosed in terms of preferred embodiments and optional features, modification of the invention herein disclosed to embody it may be noted by those skilled in the art, and such modifications and variations are considered to be within the scope of the invention.
Compared with the prior art, the invention has the beneficial effects that:
(1) the Chinese herbal medicine system infant hip-protecting cream provided by the invention extracts high-purity plant extracts, so that the product is warm, moist and nourishing, strong in antibacterial action, unchanged in effect stability, free of stimulation to human skin and free of toxic and side effects;
(2) the infant hip care cream adopts a Chinese herbal medicine antiseptic system, Chinese herbal medicine components serve as the antiseptic system in the hip care cream, and the problem of skin inflammation is radically solved;
(3) the Chinese herbal medicine system infant hip-protecting cream is particularly suitable for tender skin of infants, is moist, non-greasy, good in texture, easy to smear and absorb, mild and fresh, moistens and protects tender skin of infants, and avoids 'red butt'.
Detailed Description
For better explanation of the present invention, the following specific examples are further illustrated, but the present invention is not limited to the specific examples.
Example 1
The Chinese herbal medicine system infant hip-protecting cream is prepared from the following components in parts by weight:
mixing petrolatum, liquid paraffin, zinc oxide, microcrystalline wax and gluconolactone, and heating to 80-85 ℃ to melt the mixture completely;
adding tocopherol acetate, bisabolol, camellia seed oil, dioctyl carbonate, macadamia ternifolia seed oil and panthenol into the melted mixed grease, stirring and mixing, and keeping the temperature to obtain an oil phase;
dissolving semen gossypii extract, cortex moutan/root extract, Scutellariae radix extract, fructus Oleae Europaeae extract, herba Sidae Rhombifoliae extract, glycerol, and hexanediol in deionized water, placing in another container, and heating to 80 deg.C to obtain water phase;
slowly adding the oil phase into the water phase under continuous stirring, and grinding to emulsify the oil phase;
and when the temperature is reduced to 50 ℃, adding bergamot fruit oil, fully grinding until complete emulsification, and cooling to room temperature to obtain the hip-protecting ointment.
Example 2
The Chinese herbal medicine system infant hip-protecting cream is prepared from the following components in parts by weight:
the procedure was similar to example 1.
Example 3
The Chinese herbal medicine system infant hip-protecting cream is prepared from the following components in parts by weight:
the procedure was similar to example 1.
Comparative example 1
The hip-protecting cream is prepared from the following components in parts by weight:
the hip-care cream of comparative example 1 does not contain the moutan bark/root extract and the scutellaria baicalensis extract, and the remaining components are the same as those of the infant hip-care cream of the Chinese herbal medicine system of example 1.
Comparative example 2
The hip-protecting cream is prepared from the following components in parts by weight:
the hip-care cream of comparative example 2 did not contain the gossypium herbaceum seed extract, moutan bark/root extract, and scutellaria baicalensis extract, and the remaining ingredients were the same as those of the infant hip-care cream of the chinese herbal medicine system of example 1.
And (3) evaluating the product effect:
experiment one: heavy metal and microorganism detection assay
Detecting items: lead, mercury, arsenic, total number of colonies, total number of molds and yeasts, faecal coliform, staphylococcus aureus, pseudomonas aeruginosa.
The detection basis is as follows: QB/T1857-
The results are shown in table 1: the detected items conform to the specification of QB/T1857-2013 standard.
Table 1: test results of hip-pads in examples 1 to 3
Experiment two: skin irritation/Corrosion test (multiple skin irritation test)
Skin-friendly stimulation experiments were performed on the hip-pads of examples 1 to 3 and comparative examples 1 to 2, and 4 rabbits were selected for each experimental example. Laboratory temperature: 20-24 ℃, relative humidity: 60 to 70 percent. Approximately 24h prior to the trial, animals were clipped to remove hair from both sides of the spine in the back to a range of 2 x 3 cm. The application area was 2.5 x 2.5 cm. Applying about 0.5ml of hip-protecting ointment on one side of skin, and applying solvent on the other side of the skin as control when the test object is prepared with non-irritant solvent for 1 time per day for 14 days. From the next day, the hair should be cut and the residual test substance removed with water or a non-irritating solvent before each application. The results were observed after one hour and were scored for irritation response as specified in the cosmetic hygiene code (2007 edition), and the results of the skin acute irritation test are shown in table 2:
the test result shows that the hip-protecting cream has mild property, and the skin irritation test result shows that the hip-protecting cream has no acute skin irritation.
Experiment three, efficacy experiment:
test objects: in order to meet the diagnosis standard of diaper dermatitis of infants, the skin of a mild infant patient is not damaged, flaky erythema can be seen on the covered parts of the diaper, such as perineum, scrotum, inner thigh, buttocks and the like, the flaky erythema is matched with the covered area of the diaper, and the edge is clear. Infants between 0 and 3 years of age, male and female are not limited, no moisturizers, antihistamines, and topical glucocorticoids were used in the lesion area one month prior to the study, and the subject's guardian must ensure that various other products, hip pads, glucocorticoid ointments, etc., must not be used in the lesion area during the 24 hour period prior to assessment.
The experimental steps are as follows: the number of completed cases was 28, and example 1 containing the antibacterial preservative ingredient of the Chinese herbal medicines and comparative examples 1 and 2 not contained were compared.
Before the hip protection cream is coated, the part needing to be coated is washed clean by warm water and is lightly wiped dry by soft cloth, the hip protection cream is coated on an affected part, the thickness of the hip protection cream is about 0.5-1mm, the hip protection cream is coated twice every day, and the hip protection cream is observed on the first day, the second day, the third day, the fourth day, the fifth day, the sixth day and the seventh day respectively, the red hip disappears as the cure time during the observation period, the time is recorded as the red hip disappearance days, and the corresponding accumulated cure case number and the corresponding time are recorded by analogy.
The experimental results are as follows: cumulative number of red hip loss cases-time statistics are given in table 3 below:
and (4) experimental conclusion: the hip-protecting cream product can promote the recovery of mild red hips and has better effect on the mild red hips. In addition, the herbal system infant hip cream of example 1 (examples 2 to 3 have similar effects to example 1) can be absorbed and repaired more quickly. In addition, the gossypium herbaceum seed extract in the formula of the invention is compatible with other components, especially the peony extract and the scutellaria baicalensis extract, so that the effect of healing red buttocks can be synergistically increased.
In addition, according to the cosmetic stability test which is commonly used in the industry, the long-term stability of the product of the invention, such as a high and low temperature storage stability test, a viscosity regulation test, a packaging stability test, a color stability test and the like, is tested, and the detection result of the product of the invention is qualified.
The above description is only exemplary of the present invention and is not intended to limit the scope of the present invention, which is defined by the claims appended hereto, as well as the appended claims.
Claims (10)
3. the herbal system infant hip care cream of claim 1, wherein the skin conditioning agent comprises at least one of camellia seed oil, gossypium herbaceum seed extract, tocopheryl acetate, bisabolol, macadamia ternifolia seed oil, olea europaea fruit extract, calendula officinalis extract, panthenol, and glycerin.
4. The herbal system infant hip care cream of claim 1, wherein the herbal antimicrobial preservative further comprises at least one of an extract of phellodendron amurense, an extract of achyranthes bidentata, an extract of polygonum cuspidatum, an extract of rheum officinale, an extract of paeonia lactiflora pall, an extract of mentha haplocalyx, and an extract of oldenlandia diffusa.
5. The herbal system infant hip care cream of claim 1, wherein the oil comprises at least one of petrolatum, liquid paraffin, microcrystalline wax, gluconolactone, dioctyl carbonate, coconut oil, palm oil, mango seed butter, cocoa seed butter, beeswax, and lanolin.
6. The herbal system infant hip care cream of claim 1, wherein the supplementary aid comprises at least one of zinc oxide, propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, heptylene glycol, and octylene glycol.
7. The herbal system infant hip care cream according to claim 1, wherein the herbal antibacterial preservative comprises the following components in a weight ratio of 0.5-2: 1 peony extract and scutellaria extract.
8. The herbal system infant hip care cream of claim 1, wherein the herbal system infant hip care cream is free of non-herbal preservatives including phenoxyethanol, dichlorobenzyl alcohol, phenoxyisopropanol, benzalkonium chloride, imidazolidinyl urea, bis (hydroxymethyl) imidazolidinyl urea, benzyl alcohol, benzoic acid, salicylic acid, boric acid, sorbic acid, potassium sorbate, sodium benzoate, chlorphenesin, methylchloroisothiazolinone, methylisothiazolinone.
9. The herbal system infant hip care cream of claim 1, wherein the fragrance comprises at least one of lemon fruit oil, sweet orange fruit oil, tangerine fruit oil, grapefruit fruit oil.
10. The method of preparing a herbal system infant hip care cream according to any one of claims 1 to 9, comprising the steps of: mixing the components according to the proportion.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011127148.3A CN112315860A (en) | 2020-10-20 | 2020-10-20 | Chinese herbal medicine system infant hip-protecting cream and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011127148.3A CN112315860A (en) | 2020-10-20 | 2020-10-20 | Chinese herbal medicine system infant hip-protecting cream and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN112315860A true CN112315860A (en) | 2021-02-05 |
Family
ID=74311171
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011127148.3A Pending CN112315860A (en) | 2020-10-20 | 2020-10-20 | Chinese herbal medicine system infant hip-protecting cream and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112315860A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115569093A (en) * | 2022-09-09 | 2023-01-06 | 安徽亿人安股份有限公司 | A skin care cream with antibacterial effect for infant with dampness eliminating effect, and its preparation method |
CN116327620A (en) * | 2023-04-12 | 2023-06-27 | 广州芭妍化妆品有限公司 | Calendula skin care oil for infants and preparation method thereof |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107019659A (en) * | 2017-04-27 | 2017-08-08 | 福建春辉生物工程有限公司 | Baby's diaper ointment |
CN108042380A (en) * | 2017-12-26 | 2018-05-18 | 深圳市芭格美生物科技有限公司 | A kind of infant's activity stern protection cream and preparation method thereof |
CN110638727A (en) * | 2019-11-14 | 2020-01-03 | 广州一一生物技术有限公司 | Infant hip-protecting composition and preparation method and application thereof |
CN110721150A (en) * | 2019-11-29 | 2020-01-24 | 广州环亚化妆品科技有限公司 | Baby hip-protecting cream and preparation method thereof |
-
2020
- 2020-10-20 CN CN202011127148.3A patent/CN112315860A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107019659A (en) * | 2017-04-27 | 2017-08-08 | 福建春辉生物工程有限公司 | Baby's diaper ointment |
CN108042380A (en) * | 2017-12-26 | 2018-05-18 | 深圳市芭格美生物科技有限公司 | A kind of infant's activity stern protection cream and preparation method thereof |
CN110638727A (en) * | 2019-11-14 | 2020-01-03 | 广州一一生物技术有限公司 | Infant hip-protecting composition and preparation method and application thereof |
CN110721150A (en) * | 2019-11-29 | 2020-01-24 | 广州环亚化妆品科技有限公司 | Baby hip-protecting cream and preparation method thereof |
Non-Patent Citations (1)
Title |
---|
南京药学院: "《中草药学 下 中草药化学》", 31 May 1975, 南京药学院出版发行 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115569093A (en) * | 2022-09-09 | 2023-01-06 | 安徽亿人安股份有限公司 | A skin care cream with antibacterial effect for infant with dampness eliminating effect, and its preparation method |
CN115569093B (en) * | 2022-09-09 | 2023-10-13 | 安徽亿人安股份有限公司 | Infant dampness-dispelling skin-care cream with antibacterial effect and preparation method thereof |
CN116327620A (en) * | 2023-04-12 | 2023-06-27 | 广州芭妍化妆品有限公司 | Calendula skin care oil for infants and preparation method thereof |
CN116327620B (en) * | 2023-04-12 | 2023-11-07 | 广州芭妍化妆品有限公司 | Calendula skin care oil for infants and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN113244151B (en) | Soothing repair cream and preparation method thereof | |
Aburjai et al. | Plants used in cosmetics | |
CN108743474B (en) | Ointment-shaped baby hip-protecting cream and preparation method thereof | |
KR100960054B1 (en) | Hair cosmetic composition for improving stste of scalp and preventing fall-out of hair | |
CN107550808B (en) | Moisturizing infant hip-protecting emulsion for removing diaper rash and preparation method thereof | |
CN113197836A (en) | Moisturizing, relieving, itching-relieving and skin-protecting cream and preparation method thereof | |
KR100701606B1 (en) | The cosmetic composition with a herb medicine extract and the producing method thereof | |
CN106074306A (en) | A kind of for skin and the compositions of hair maintenance and application | |
KR20080002279A (en) | Lip cosmetic composition for atopy skin | |
KR101724147B1 (en) | Cosmetic composition having anti-itching effect containing crude drug extracts | |
CN111529477A (en) | Composition for caring hair, and preparation and application thereof | |
CN112315860A (en) | Chinese herbal medicine system infant hip-protecting cream and preparation method thereof | |
CN110946817A (en) | Natural herbal skin mucosa disinfectant special for private parts of women | |
CN109793696B (en) | Anti-dandruff plant composition and preparation method and application thereof | |
KR101585922B1 (en) | Preparation method for natural shampoo composition comprising plant extracts and natural surfactant | |
CN114533624A (en) | White hair blackening liquid and preparation method thereof | |
KR20200073970A (en) | Soothing cream and manufacturing method for the same | |
CN112569163A (en) | Anti-allergy repair emulsion without preservative and preparation method thereof | |
CN109939193A (en) | A kind of composition for treating skin eczema, preparation and preparation method and application | |
CN102872240B (en) | Compound essential oil for relaxing and activating collaterals | |
US20180168952A1 (en) | Composition and application in baby lotion thereof | |
CN112156058A (en) | Infant moisturizing lotion and preparation method thereof | |
CN106344460A (en) | Special moisturizing and acne-removing face cream for acne-prone skin and preparation method thereof | |
CN111228154A (en) | Fresh wheat extract protoplasm milk for infants and preparation method thereof | |
CN110613663A (en) | Skin repairing composition, skin care product and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210205 |